BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2010
View Archived Issues
Endece's novel ER agonists block chromosome replication and show antitumor activity in vivo
Read More
Actelion claims novel calcium channel blockers
Read More
INS-115644 reduces IOP in glaucoma, ocular hypertension patients
Read More
Novel antifungal agents identified by Indian scientists
Read More
Bristol-Myers Squibb claims novel MCH-R1 antagonists
Read More
Basilea Pharmaceutica's novel tubulin polymerization inhibitors show promising preclinical activity
Read More
Novel anti-PLGF murine monoclonal antibody P-16 displays potent antitumor activity in vivo
Read More
Presidio reports preclinical data on its novel HCV NS5A inhibitor PPI-461
Read More
VAX-102 increases immune response to trivalent influenza vaccine
Read More
Promising phase II data on JX-594 in HCC support phase III evaluation
Read More
Chimerix initiates first-in-human phase I study of CMX-157
Read More
Array BioPharma discloses novel Trk kinase inhibitors
Read More
DMC recommends continuation of phase III ThermoDox HEAT study
Read More
Merck & Co. identifies novel orexin receptor antagonists
Read More
Repligen files IND with FDA for Friedreich's ataxia drug
Read More
Meda acquires European rights from Graceway to new imiquimod formulation for AK
Read More
Rexahn to move forward with phase IIb trial of Zoraxel for ED
Read More
Octapharma launches Wilate for von Willebrand disease
Read More
FDA assigns November 4, 2010 action date for Cadence's Ofirmev NDA
Read More
Roche to begin study of TB-403 in patients with colorectal and ovarian cancer
Read More
Amgen submits BLA for denosumab for skeletal-related events in cancer patients
Read More
SRI International's SR-16388 has promise for multiple myeloma
Read More
Astellas to acquire OSI Pharmaceuticals
Read More
FDA recommends resumption of use of Rotarix
Read More
Lundbeck announces results of pivotal Japanese study of escitalopram
Read More
SciClone provides update on clinical program for SCV-07 in oral mucositis
Read More